Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

October 31, 2010

Conditions
Bladder Cancer Recurrence
Trial Locations (20)

10016

University Urology Associates, New York

12208

Capital Regional Urological Surgeons, Albany

Community Care Physicians, Albany

12601

Hudson Valley Urology, Poughkeepsie

13210

Associated Medical Professionals, Syracuse

15212

Triangle Urologic Group, Pittsburgh

17601

Urological Associates of Lancaster, Lancaster

29572

Carolina Urologic Research Center, Myrtle Beach

32114

Atlantic Urological Associates, Daytona Beach

32803

Winter Park Urology, Orlando

45212

The Urology Group, Cincinnati

47130

Metropolitan Urology, Jeffersonville

55125

Metro Urology, Woodbury

55901

Mayo Validation Support Services, Rochester

75231

Urology Clinics of North Texas, Dallas

78229

Urology San Antonio Research, San Antonio

80113

Urology Associates, Engelwood

85032

BCG Oncology, Phoenix

07052

Associates in Urology/Urology Group of NJ, 741 Northfield Avenue

08723

Coastal Urology Associates, Brick

Sponsors
All Listed Sponsors
lead

Predictive Biosciences

INDUSTRY